OQROStart free trial
Insider trade

Medtronic (MDT): EVP & Pres Neuroscience sold ~$1.12M

Brett A. Wall, EVP & Pres Neuroscience at Medtronic, sold ~$1.12M of Medtronic shares.

~$1.12M
Approx. value · 12K sh @ $90.00
41K
Holds after · shares reported
Traded
Jan 24, 2025
Filed
Jan 27, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 6, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  2. Jan 8, 2025Insider · 1 personInsiders: 2 sales (~$792K)
  3. Jan 24, 2025 · this disclosureInsiderOfficer sold ~$1.12M of MDT shares in the open market

What came next

  1. Jan 31, 2025FDARecall: MiniMed insulin pump, REF: 770G (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)
  2. Feb 5, 2025FDARecall: Aortic Root Cannula: 1. DLP Aortic Root Cannula A. CANNULA 11012 AR FLOWGUARD 12GA, model no 11012 B. CANNULA 11014 AR FLOWGUARD 14GA, model no. 11014 2. MiAR…
  3. Feb 25, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  4. Feb 26, 2025FDARecall: Shiley Adult Flexible Tracheostomy Tube with TaperGuard Cuff Reusable Inner Cannula, REF: 7CN80R
  5. Mar 4, 2025FDARecall: InPen smart insulin pen, REF: MMT-105NNBLNA, MMT-105NNGYNA, MMT-105NNPKNA, MMT-105ELBLNA, MMT-105ELGYNA, MMT105ELPKNA
  6. Mar 4, 2025FDARecall: Stimulation RC Clinician Programmer Application, Model A71400, when used with the Inceptiv (Model 977119) and Intellis Pro (Model 977118) neurostimulators
  7. Mar 4, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  8. Mar 10, 2025FDAFDA device clearance: Duet External Drainage and Monitoring System (EDMS)
  9. Mar 10, 2025FDARecall: NIM Vital Nerve Monitoring System: CONSOLE NIM4CM01 NIM 4.0, REF: NIM4CM01; CONSOLE NIM4CM01RF NIM 4.0 REFURBISHED, REF: NIM4CM01RF; PATIENT INTERFACE NIM4CPB1…
  10. Mar 20, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  11. Mar 24, 2025CongressDisclosed sale of MDT — reported range $50,001 - $100,000
  12. Mar 27, 2025FDAFDA device clearance: SelectSite C304 Deflectable Catheter System (C304); C315 Delivery System (C315)
  13. Apr 3, 2025FDARecall: Enhanced Verify Evaluation Handset (CFN HH90130FA)
  14. Apr 8, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  15. Apr 22, 2025FDAFDA device clearance: Adaptix™ Interbody System with Titan nanoLOCK™ Surface Technology
  16. Apr 22, 2025FDAFDA device approval: OmniaSecure™ MRI SureScan™ Lead Model 3930M
  17. Apr 29, 2025FDARecall: Azure S DR MRI SureScan, Product number W3DR01
  18. May 7, 2025FDARecall: Medtronic, Simplera Sensor, REF: MMT-5100JD1
  19. May 20, 2025FDAFDA device clearance: VitalFlow Console
  20. May 21, 2025FDARecall: Newport HT70 Ventilator, REF: HT70M-JP-NA, HT70M-CN-NA, HT70M-ES-EU, HT70M-PT-BR, HT70M-SY-EU, HT70M-WW-EU, HT70M-WW-NA, HT70-SY-EU. Newport HT70Plus Ventilato…
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Medtronic

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 40 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

Other recent filings by Brett A. Wall, EVP & Pres Neuroscience

The full history of Brett A. Wall, EVP & Pres Neuroscience is on the profile page.

How this filing works

Explore the data

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data